(Q35183961)

7 August 2017

1 reference

title

Clinically important drug interactions in epilepsy: interactions between antiepileptic drugs and other drugs (English)

1 reference

7 August 2017

2

Emilio Perucca

1 reference

7 August 2017

Philip N Patsalos

1

1 reference

7 August 2017

publication date

1 August 2003

1 reference

7 August 2017

1 reference

7 August 2017

volume

2

1 reference

7 August 2017

issue

8

1 reference

7 August 2017

page(s)

473-481

1 reference

The importance of drug interactions in epilepsy therapy

7 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900483-6

7 January 2021

Clinically important drug interactions in epilepsy: general features and interactions between antiepileptic drugs

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900483-6

7 January 2021

Phenytoin and carbamazepine decreased oral bioavailability of praziquantel

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900483-6

7 January 2021

Pharmacokinetic interaction between albendazole sulfoxide enantiomers and antiepileptic drugs in patients with neurocysticercosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900483-6

7 January 2021

Carbamazepine intoxication caused by interaction with isoniazid.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900483-6

7 January 2021

Ethosuximide intoxication caused by interaction with isoniazid

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900483-6

7 January 2021

Clinical importance of the interaction of phenytoin and isoniazid: a report from the Boston Collaborative Drug Surveillance Program

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900483-6

7 January 2021

Influence of rifampicin and isoniazid on the kinetics of phenytoin

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900483-6

7 January 2021

Antituberculosis agents and carbamazepine

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900483-6

7 January 2021

Use of single sample clearance estimates of cytochrome P450 substrates to characterize human hepatic CYP status in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900483-6

7 January 2021

Effects of rifampicin and cimetidine on pharmacokinetics and pharmacodynamics of lamotrigine in healthy subjects

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900483-6

7 January 2021

Panipenem-betamipron and decreases in serum valproic acid concentration

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900483-6

7 January 2021

Lowering of plasma valproic acid concentrations during concomitant therapy with meropenem and amikacin

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900483-6

7 January 2021

Carbapenem antibiotics inhibit valproic acid transport in Caco-2 cell monolayers

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900483-6

7 January 2021

Pharmacologic interactions among chloramphenicol, phenytoin and phenobarbital.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900483-6

7 January 2021

Drug interactions with clinafloxacin

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900483-6

7 January 2021

Factors contributing to carbamazepine-macrolide interactions

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900483-6

7 January 2021

Interaction between erythromycin and the benzodiazepines diazepam and flunitrazepam.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900483-6

7 January 2021

Evaluation of the potential interaction between felbamate and erythromycin in patients with epilepsy.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900483-6

7 January 2021

Lack of pharmacokinetic interaction between tiagabine and erythromycin

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900483-6

7 January 2021

Absence of interaction between oxcarbazepine and erythromycin

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900483-6

7 January 2021

Interaction between Doxycycline and some Antiepileptic Drugs

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900483-6

7 January 2021

Metabolism-based drug interactions involving oral azole antifungals in humans

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900483-6

7 January 2021

Potential fluconazole-induced carbamazepine toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900483-6

7 January 2021

Phenytoin intoxication during treatment with parenteral miconazole

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900483-6

7 January 2021

Fluconazole-induced symptomatic phenytoin toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900483-6

7 January 2021

Elevation of plasma carbamazepine concentrations by ketoconazole in patients with epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900483-6

7 January 2021

Itraconazole and hydroxyitraconazole serum concentrations are reduced more than tenfold by phenytoin

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900483-6

7 January 2021

Interaction of metronidazole with phenobarbital, cimetidine, prednisone, and sulfasalazine in Crohn's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900483-6

7 January 2021

Seizures in human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900483-6

7 January 2021

Therapeutic dilemma: the use of anticonvulsants in HIV-positive individuals

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900483-6

7 January 2021

Carbamazepine--indinavir interaction causes antiretroviral therapy failure.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900483-6

7 January 2021

Pharmacokinetic interaction between zidovudine and valproic acid in patients infected with human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900483-6

7 January 2021

Protease inhibitor-induced carbamazepine toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900483-6

7 January 2021

Enantioselective induction of cyclophosphamide metabolism by phenytoin.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900483-6

7 January 2021

Phenytoin-induced alteration in the N-dechloroethylation of ifosfamide stereoisomers

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900483-6

7 January 2021

Influence of prophylactic anticonvulsant therapy on high-dose busulphan kinetics.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900483-6

7 January 2021

Increased teniposide clearance with concomitant anticonvulsant therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900483-6

7 January 2021

Preirradiation paclitaxel in glioblastoma multiforme: efficacy, pharmacology, and drug interactions. New Approaches to Brain Tumor Therapy Central Nervous System Consortium

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900483-6

7 January 2021

Adverse effect of anticonvulsants on efficacy of chemotherapy for acute lymphoblastic leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900483-6

7 January 2021

Phenytoin and fluorouracil interaction

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900483-6

7 January 2021

Probable metabolic interaction of doxifluridine with phenytoin

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900483-6

7 January 2021

High-dose tamoxifen in treatment of brain tumors: interaction with antiepileptic drugs

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900483-6

7 January 2021

Possible interaction involving phenytoin, dexamethasone, and antineoplastic agents: a case report and review

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900483-6

7 January 2021

Decreased phenytoin level after carboplatin treatment.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900483-6

7 January 2021

An interaction between cytostatic and anticonvulsant drugs

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900483-6

7 January 2021

Interference of high-dose methotrexate in the metabolism of valproate?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900483-6

7 January 2021

Nitroso-urea-cisplatin-based chemotherapy associated with valproate: increase of haematologic toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900483-6

7 January 2021

The effect of enzyme induction on the metabolism of disopyramide in man.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900483-6

7 January 2021

Effect of phenytoin on the clinical pharmacokinetics of amiodarone.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900483-6

7 January 2021

Steady-state interaction between amiodarone and phenytoin in normal subjects

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900483-6

7 January 2021

Implications of cytochrome P450 interactions when prescribing medication for hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900483-6

7 January 2021

Differential effects of valproic acid and enzyme-inducing anticonvulsants on nimodipine pharmacokinetics in epileptic patients

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900483-6

7 January 2021

Reduced plasma nisoldipine concentrations in phenytoin-treated patients with epilepsy.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900483-6

7 January 2021

Evaluation of potential losartan-phenytoin drug interactions in healthy volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900483-6

7 January 2021

Interactions between calcium channel blockers and the anticonvulsants carbamazepine and phenytoin

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900483-6

7 January 2021

Verapamil potentiates carbamazepine neurotoxicity: a clinically important inhibitory interaction

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900483-6

7 January 2021

Ticlopidine inhibition of phenytoin metabolism mediated by potent inhibition of CYP2C19

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900483-6

7 January 2021

On the interaction between phenytoin and digoxin

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900483-6

7 January 2021

Tiagabine, a novel antiepileptic agent: lack of pharmacokinetic interaction with digoxin.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900483-6

7 January 2021

Repeated administration of the novel antiepileptic agent levetiracetam does not alter digoxin pharmacokinetics and pharmacodynamics in healthy volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900483-6

7 January 2021

Efficacy of statin therapy: possible effect of phenytoin

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900483-6

7 January 2021

Clinically significant drug interactions with the oral anticoagulants

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900483-6

7 January 2021

Warfarin-felbamate interaction: first report

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900483-6

7 January 2021

Oxcarbazepine does not affect the anticoagulant activity of warfarin

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900483-6

7 January 2021

Lack of effect of repeated administration of levetiracetam on the pharmacodynamic and pharmacokinetic profiles of warfarin

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900483-6

7 January 2021

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900483-6

1 reference

7 January 2021

Differential effect of cimetidine on serum concentrations of carbamazepine and phenytoin.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900483-6

7 January 2021

Cimetidine and carbamazepine: a complex drug interaction

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900483-6

7 January 2021

Oxcarbazepine does not interact with cimetidine in healthy volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900483-6

7 January 2021

Oral phenytoin pharmacokinetics during omeprazole therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900483-6

7 January 2021

Effect of omeprazole on the pharmacokinetics of sustained-release carbamazepine in healthy male volunteers.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900483-6

7 January 2021

St John's Wort: effect on CYP3A4 activity

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900483-6

7 January 2021

Lack of effect of St John's Wort on carbamazepine pharmacokinetics in healthy volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900483-6

7 January 2021

Analysis of a clinically important interaction between phenytoin and Shankhapushpi, an Ayurvedic preparation

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900483-6

7 January 2021

Herb-drug interactions

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900483-6

7 January 2021

Herbal medicinals: selected clinical considerations focusing on known or potential drug-herb interactions

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900483-6

7 January 2021

Clinically significant drug interactions with cyclosporin. An update

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900483-6

7 January 2021

Evaluation of cyclosporin-phenytoin interaction with observations on cyclosporin metabolites

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900483-6

7 January 2021

Possible oxcarbazepine interaction with cyclosporine serum levels: a single case study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900483-6

7 January 2021

Valproate for epilepsy in renal transplant recipients receiving cyclosporine

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900483-6

7 January 2021

Important interactions of drugs with immunosuppressive agents used in transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900483-6

7 January 2021

Tacrolimus-phenytoin interaction

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900483-6

7 January 2021

Phenytoin decreases the blood concentrations of sirolimus in a liver transplant recipient: a case report

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900483-6

7 January 2021

Clinical significance of pharmacokinetic interactions between antiepileptic and psychotropic drugs

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900483-6

7 January 2021

Phenobarbital induces the 2-hydroxylation of desipramine

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900483-6

7 January 2021

Pharmacokinetic interaction between imipramine and carbamazepine in patients with major depression

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900483-6

7 January 2021

Carbamazepine-nefazodone interaction in healthy subjects

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900483-6

7 January 2021

Carbamazepine augmentation in depressive patients non-responding to citalopram: a pharmacokinetic and clinical pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900483-6

7 January 2021

Carbamazepine but not valproate induces bupropion metabolism.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900483-6

7 January 2021

Status epilepticus associated with the combination of valproic acid and clomipramine

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900483-6

7 January 2021

Phenytoin intoxication induced by fluvoxamine

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900483-6

7 January 2021

Carbamazepine-viloxazine interaction in patients with epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900483-6

7 January 2021

Interaction between trazodone and carbamazepine

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900483-6

7 January 2021

A sertraline/valproic acid drug interaction: Case Reports

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900483-6

7 January 2021

Lamotrigine toxicity secondary to sertraline

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900483-6

7 January 2021

Effects of carbamazepine and valproate on haloperidol plasma levels and on psychopathologic outcome in schizophrenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900483-6

7 January 2021

Effect of switching carbamazepine to oxcarbazepine on the plasma levels of neuroleptics. A case report

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900483-6

7 January 2021

Carbamazepine-induced changes in plasma levels of neuroleptics

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900483-6

7 January 2021

Inducing effect of phenobarbital on clozapine metabolism in patients with chronic schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900483-6

7 January 2021

A pharmacokinetic interaction between carbamazepine and olanzapine: observations on possible mechanism

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900483-6

7 January 2021

Adverse drug interaction between risperidone and carbamazepine in a patient with chronic schizophrenia and deficient CYP2D6 activity.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900483-6

7 January 2021

The effects of concomitant phenytoin administration on the steady-state pharmacokinetics of quetiapine

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900483-6

7 January 2021

Plasma concentrations of risperidone and 9-hydroxyrisperidone: effect of comedication with carbamazepine or valproate

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900483-6

7 January 2021

Carbamazepine-risperidone interactions in patients with epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900483-6

7 January 2021

Effect of valproate on the pharmacokinetics and pharmacodynamics of lorazepam

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900483-6

7 January 2021

Valproic acid and diazepam interaction in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900483-6

7 January 2021

Concentrations and effects of oral midazolam are greatly reduced in patients treated with carbamazepine or phenytoin.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900483-6

7 January 2021

Phenytoin/dexamethasone interaction: A clinical problem

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900483-6

7 January 2021

Adverse Effects of Phenobarbital on Corticosteroid Metabolism in Patients with Bronchial Asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900483-6

7 January 2021

Effects of enzyme induction on metabolism of prednisolone. Clinical and laboratory study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900483-6

7 January 2021

Clinically significant danazol-carbamazepine interaction

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900483-6

7 January 2021

The interaction of phenytoin and carbamazepine with combined oral contraceptive steroids

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900483-6

7 January 2021

Induction of ethinylestradiol and levonorgestrel metabolism by oxcarbazepine in healthy women

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900483-6

7 January 2021

Effects of felbamate on the pharmacokinetics of a low-dose combination oral contraceptive

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900483-6

7 January 2021

Effect of topiramate on the pharmacokinetics of an oral contraceptive containing norethindrone and ethinyl estradiol in patients with epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900483-6

7 January 2021

Effect of topiramate or carbamazepine on the pharmacokinetics of an oral contraceptive containing norethindrone and ethinyl estradiol in healthy obese and nonobese female subjects

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900483-6

7 January 2021

Interactions between antiepileptic drugs and hormonal contraception

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900483-6

7 January 2021

The lack of effect of sodium valproate on the pharmacokinetics of oral contraceptive steroids

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900483-6

7 January 2021

Gabapentin does not interact with a contraceptive regimen of norethindrone acetate and ethinyl estradiol

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900483-6

7 January 2021

Levetiracetam does not alter the pharmacokinetics of an oral contraceptive in healthy women

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900483-6

7 January 2021

A double-blind, placebo-controlled study on the effect of vigabatrin on in vivo parameters of hepatic microsomal enzyme induction and on the kinetics of steroid oral contraceptives in healthy female volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900483-6

7 January 2021

Lamotrigine plasma levels reduced by oral contraceptives

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900483-6

7 January 2021

10.1016/S1474-4422(03)00483-6

Identifiers

DOI

1 reference

7 August 2017

1 reference